EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Interactions Between Endocannabinoid and Endogenous Opioid Systems Prospectively Influence Postoperative Opioid Use in Pregnant Patients Undergoing Cesarean Delivery

Amanda L Stone, Amelie Pham, Sarah S Osmundson, Alex Pedowitz, Philip J Kingsley, Larry J Marnett, Sachin Patel, Nancy Wickersham, Laura L Sorabella, Stephen Bruehl

The Journal of Pain · 2024

DOI: 10.1016/j.jpain.2024.104548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pain, 2024. Verfasst von Amanda L Stone und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Endocannabinoids, Cesarean Section, Postoperative Pain, Analgesics, Opioid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NICHD NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Both endocannabinoid (EC) and endogenous opioid systems are involved in nociceptive processing and may work together synergistically based on preclinical models. This study evaluated the interactive effects of preoperative beta-endorphin (BE) concentrations (a key analgesic endogenous opioid) in cerebrospinal fluid (CSF) and ECs (CSF and plasma 2-arachidonoylglycerol and plasma anandamide) on postoperative opioid use and pain intensity in a prospective cohort of n = 112 pregnant patients undergoing scheduled cesarean delivery. Maternal blood and CSF samples were collected preoperatively for BE and EC assays. Patients completed measures of outpatient opioid use (number of tablets used and days of use) and average pain intensity at 2 weeks postoperatively. Results of general linear model analyses controlling for maternal age, body mass index at time of delivery, and race revealed significant multiplicative interactions between EC and BE concentrations on number of opioid tablets used (based on pill count), days of opioid use, and total milligram morphine equivalents used in the 2-week follow-up period. Elevated preoperative plasma and CSF 2-arachidonoylglycerol predicted reduced outpatient opioid analgesic use, particularly for patients low in CSF BE. Similar analyses for pain intensity at 2-week follow-up indicated a significant interaction (P < .02) characterized by higher preoperative BE concentrations being associated with lower subsequent pain only for individuals with low preoperative plasma anandamide concentrations. Further exploration of interactions between EC and endogenous opioid inhibitory systems as they influence responses to opioid analgesics in other clinical pain populations may help guide the development of precision pain management approaches. PERSPECTIVE: In the postoperative setting of patients undergoing cesarean delivery, elevated ECs were linked to reduced outpatient opioid analgesic use in individuals who had low endogenous opioid concentrations in CSF. Further exploration of interactions between these 2 inhibitory systems as they impact responses to pain management interventions appears warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsCesarean SectionPostoperative PainAnalgesics, OpioidGlyceridesPolyunsaturated AlkamidesArachidonic AcidsHumansFemalePregnancyAdultbeta-EndorphinProspective StudiesYoung Adult

Stichwörter der Autor:innen

EndocannabinoidEndogenous opioidbeta-endorphinopioid usepostoperative pain

Substanzen

EndocannabinoidsAnalgesics, OpioidGlyceridesanandamidePolyunsaturated AlkamidesArachidonic Acidsglyceryl 2-arachidonatebeta-Endorphin

Autor:innen und Institutionen

  • Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Miller School of Medicine, University of Miami, Miami, Florida.
  • Department of Biochemistry, Vanderbilt University, Nashville, Tennessee; A.B. Hancock Memorial Laboratory for Cancer Research, Vanderbilt University, Nashville, Tennessee.
  • Department of Biochemistry, Vanderbilt University, Nashville, Tennessee.
  • Department of Psychiatry, Northwestern University School of Medicine, Chicago, Illinois.

Förderung

  • NIDA NIH HHS
  • NICHD NIH HHS
  • NIH

Zitieren

APA

Stone, A. L., Pham, A., Osmundson, S. S., Pedowitz, A., Kingsley, P. J., Marnett, L. J., Patel, S., Wickersham, N., Sorabella, L. L., & Bruehl, S. (2024). Interactions Between Endocannabinoid and Endogenous Opioid Systems Prospectively Influence Postoperative Opioid Use in Pregnant Patients Undergoing Cesarean Delivery. The Journal of Pain. https://doi.org/10.1016/j.jpain.2024.104548

Vancouver

Stone AL, Pham A, Osmundson SS, Pedowitz A, Kingsley PJ, Marnett LJ, et al. Interactions Between Endocannabinoid and Endogenous Opioid Systems Prospectively Influence Postoperative Opioid Use in Pregnant Patients Undergoing Cesarean Delivery. The Journal of Pain. 2024. doi:10.1016/j.jpain.2024.104548

BibTeX
@article{Stone2024,
  author = {Stone, Amanda L and Pham, Amelie and Osmundson, Sarah S and Pedowitz, Alex and Kingsley, Philip J and Marnett, Larry J and Patel, Sachin and Wickersham, Nancy and Sorabella, Laura L and Bruehl, Stephen},
  title = {Interactions Between Endocannabinoid and Endogenous Opioid Systems Prospectively Influence Postoperative Opioid Use in Pregnant Patients Undergoing Cesarean Delivery},
  journal = {The Journal of Pain},
  year = {2024},
  doi = {10.1016/j.jpain.2024.104548}
}
Kostenlos starten →